Sahil Kirpekar is Chief Business Officer of ATAI Life Sciences N.V.. Currently has a direct ownership of 115,636 shares of ATAI, which is worth approximately $164,203. The most recent transaction as insider was on Mar 21, 2025, when has been sold 48,563 shares (Common Shares) at a price of $1.35 per share, resulting in proceeds of $65,560. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
80.12% 3M change
80.12% 12M change
Total Value Held $164,203

Sahil Kirpekar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2025
SELL
Open market or private sale
$65,560 $1.35 p/Share
48,563 Reduced 29.58%
115,636 Common Shares
Mar 14 2025
BUY
Exercise of conversion of derivative security
-
100,000 Added 37.85%
164,199 Common Shares
Apr 02 2024
SELL
Open market or private sale
$66,231 $1.85 p/Share
35,801 Reduced 35.8%
64,199 Common Shares
Mar 14 2024
BUY
Exercise of conversion of derivative security
-
100,000 Added 50.0%
100,000 Common Shares
SK

Sahil Kirpekar

Chief Business Officer
Berlin, 2M

Track Institutional and Insider Activities on ATAI

Follow ATAI Life Sciences N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATAI shares.

Notify only if

Insider Trading

Get notified when an Atai Life Sciences N.V. insider buys or sells ATAI shares.

Notify only if

News

Receive news related to ATAI Life Sciences N.V.

Track Activities on ATAI